If you arent familiar, peptides are short strings of amino acids produced by your body linked via peptide bonds. Amino acids are the building blocks of proteins, but a peptide doesn't have as many amino acids as a protein does. When organized in complex structures (typically consisting of 50 or more amino acids), peptides then become proteins. We have utilized peptides at The Institute for a number of years because they have so many functions, namely, they engage with various receptors throughout the body, promoting therelease of hormones and other messaging compounds that may influence your health, body composition, exercise performance and recovery. The body produces a wide range of peptide hormones that circulate in the blood and bind to receptors on targeted organs and tissues. In fact, our patches contain a variety of peptides and peptide hormones. These are mixed with penetrating molecules to enable the peptides to reach a particular joint. We have recently decided to incorporate additional peptides into our practice because they can also stimulate the growth and health of our mitochondria and at the same time increase the length of our telomeres. Many peptides have to be taken by injection, while others can be administered orally. Our patches are a transdermal option, but often a combination of peptide delivery mechanisms will be used. Revolutionary New Peptides Were Using BPC-157 is a partial form of the protein known as body protection compound (BPC). BPC 157 is a synthetically produced peptide based off of the naturally occurring body protection compound (BPC) protein that was isolated from human gastric contents. This short peptide has been shown to have both anti-inflammatory and wound healing effect. The good news is that BPC is not just active in intestinal repair and healing, but appears to produce similar effects in a number of tissues. Scientific studies based on animal test subjects has shown that its healing actions are at least partially linked to growth hormone (GH) which is found in the velvet deer antler product that our patients get. Peptides for Wound HealingBPC-157 significantly accelerates reticulin and collagen formation as well as angiogenesis (the formation of new blood vessels) together with stimulation of macrophages and fibroblasts infiltration, representing a potential therapeutic tool in wound healing management. We must realize that in regenerative medicine most entities, be it osteoarthritis, tendon injuries, or other soft tissue injuries, are considered wounds. To that end, BPC-157 plays a significant role in fibroblast recruitment. Fibroblasts are the major cells responsible for the production of collagen, glycosaminoglycans, and proteoglycans. These compounds are considered the primary source of extracellular matrix (ECM) proteins, which, in addition to providing a scaffold for cells, play key roles in determining cell type and function. At present we will use an oral version of BPC-157. An oral route is not a problem since in a natural state BPC-157 is found in gastric juice. 14 Potential Benefits of BPC-157Accelerated wound healing (muscle, ligament, tendon, nerve)Anti-inflammatoryHas been shown to decrease pain in damaged areasBPC-157 increases growth hormone receptorsPromotes the outgrowth of tendon fibroblasts, cell survival under stress, and the migration of tendon fibroblastsImproves digestive functionMay improve blood pressure and NO productionProtects and heals inflamed intestinal epithelium (leaky gut)Has also been shown to help in inflammatory bowel diseaseProtects liver from toxic insults (alcohol, antibiotics, etc) and promotes healingAdvanced Benefits of BPC-157 include:In tendons, BPC-157 increases fibroblast growth via phosphorylation levels of both FAK and paxillin (dose dependently)In collagen repair, BPC-157 stimulates EGR-1 which induces cytokine and growth factor generation and early extracellular matrix (collagen) formationEGR-1 also increases its co-repressors such as nerve growth factor 1-A binding protein-2 (NAB2)BPC-157 can increase B4 (LTB4), thromboxane B2 (TXB2), and myeloperoxidase (MPO) in the serum and inflamed tissues and increase macrophages activity The Small Peptide: Thymosin Beta 4 Thymosin is a hormone secreted from the thymus. Its primary function is to stimulate the production of T cells, which are an important part of the immune system. Thymosin also assists in the development of B cells to plasma cells to produce antibodies. The predominant form of thymosin, thymosin beta 4, is an actin, meaning its a cell building protein. This cell-building protein is an essential component of cell structure and movement, which leads to its role in tissue repair. T4 has been found to play an important role in protection, regeneration, and remodeling of injured or damaged tissues. After an injury, T4 is released by platelets and numerous other types of cells to protect the most damaged cells and tissues, reducing inflammation and microbial growth. 14 Benefits of Thymosin Beta 4:Reduced inflammation of tissue in jointsIncreased exchange of substances between cellsEncourages the growth of new blood cells in tissueCalms muscle spasmImproved muscle toneEncourages tissue repairStretches connective tissueHelps maintain flexibilityIncreased endurance and strengthPrevents the formation of adhesions and fibrous bands in muscles, tendons, and ligamentsReduces the infarct size and improves heart contractile performanceTherapeutic effect on corneal injury and dry eye syndromeAntifibrotic effect on the liverAccelerates hair growthRecent studies have revealed that the first gene to be upregulated after an injury is a T4 gene. As the body begins the recovery process, T4 aids in the creation of new vessels in the injured area, which carry blood, nutrients, and reparative substances to the site. T4 also has anti-inflammatory properties and works to decrease the number of inflammatory cells. We will utilize an oral version in our treatments.While we currently offer BPC-157 and TB4 peptide treatments, we will likely be adding several more in the future, including the following: Mitochondrial Peptides We will also expand our repertoire to include a number of other interesting peptides as well, some of which will increase the health of our mitochondria. One such peptide is MOTS-c. MOTS-c has been shown to target the skeletal muscle and enhance glucose metabolism. As such, MOTS-c has implications in the regulation of obesity, diabetes, exercise, and longevity, representing an entirely novel mitochondrial signaling mechanism to regulate metabolism within and between cells. Remember, most diseases are in some way related to mitochondrial malfunction. Sermorelin, Ipamorelin and Other Stimulators of Growth Hormone Another set of peptides that we may utilize include sermorelin and ipamorelin, which can be used to increase the growth hormone levels in the body. Growth hormone can have many far-reaching effects, including treatment for a variety of conditions, from weight loss to increasing muscle mass and helping repair and recover from injuries. Another similar peptide is CJC-1295. CJC-1295 and ipamorelin are typically combined in therapy because they are known to work well together. These peptides allow your pituitary gland to produce the growth hormone. When one takes actual growth hormone it will diminish the production of growth hormone by the pituitary gland. IGR1-LR3 is a breakthrough peptide that has shown great results without many of the side effects or risks of other more commonly prescribed fat loss medications. IGF-1 LR3 inhibits the movement of glucose into the body's cells which facilitates fat burning and the use of fat in the body for the production of energy. It functions differently in different types of tissues. For instance, in muscle tissue, it makes the muscle more sensitive to insulins effects, such as a reduction in fat storage. Epithalon Telomere Enhancer Epithalon (also known as epitalon or epithalone) is the synthetic version of the polypeptide epithalamin, which is naturally produced in the pineal gland. Epithalons primary role is to increase the natural production of telomerase, a natural enzyme that helps cells reproduce telomeres, which are the protective parts of our DNA. This allows the replication of our DNA so the body can grow new cells and rejuvenate old ones.Each cell contains DNA as an instruction manual for how to divide and grow and the DNA inside of each cell is shielded by proteins called telomeres.During cellular division, a new cell must take some telomeres from its originating cell to shield the DNA of the new cell. The telomeres shorten after every cell division because the new cell can only take a portion of the telomeres from the previous cell, or else the previous cells DNA will become completely unprotected.Once there are no leftover telomeres to take, the cell stops dividing. This happens after a single cell divides and grows about 64 other cells, which is known as the Hayflick limit. This limit exists because cells without shield material are more vulnerable to DNA damage.If the DNA of a cell becomes damaged, the cell will follow broken instructions. If the instructions within the DNA of the cell are damaged, then the cell may not be able to eliminate itself through the process of apoptosis like it is supposed to. As time goes on we will add more and more peptides to our armamentarium. I look forward to making exciting new updates to this article on a regular basis! Dr. P NOTE: Some people are curious as to whether peptides are steroids. The answer is no. Peptides have far fewer side effects than steroids.
Read this article:
The Institute of Regenerative Medicine | Non-Surgical, Cell-Based ...
- Cell-Based Regenerative Medicine Market Size to Witness Rapid Growth at a CAGR of 15% by 2032 | insightSLICE - EIN News - May 9th, 2023
- Indian Pharma Congress: Gene-cell therapy, preventive medicine future of health care, says expert - Economic Times - January 21st, 2023
- Cell culture - Wikipedia - December 18th, 2022
- The Legacy of Henrietta Lacks - Hopkins Medicine - December 10th, 2022
- HOME | Stem cell & Cancer - October 4th, 2022
- CAR T Cell Therapy Offers a New Hope in the Treatment of Severe and Refractory Systemic Lupus Erythematosus - Rheumatology Network - October 4th, 2022
- Cell and Gene Therapy: Rewriting the Future of Medicine - Technology Networks - October 4th, 2022
- Outlook on the Automated Cell Counters Global Market to 2028 - Use of Cell Counters in Personalized Medicine Presents Opportunities -... - October 4th, 2022
- Jcr Pharmaceuticals Co., Ltd. and Sysmex Establish A Joint Venture in the Field of Regenerative Medicine and Cell Therapy - Marketscreener.com - October 4th, 2022
- Growth in Cell and Gene Therapy Market - BioPharm International - October 4th, 2022
- Breakthrough in production of cancer-treating drug - Stanford University News - October 4th, 2022
- CRISPR Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX130 for the Treatment of Cutaneous T-Cell... - October 4th, 2022
- Mary Munson elected fellow of the American Society for Cell Biology - UMass Medical School - October 4th, 2022
- 5 FDA decisions to watch in the fourth quarter - BioPharma Dive - October 4th, 2022
- bit.bio Adds Two New Human Cell Products to Address the Translation Gap and Accelerate Research and Drug Discovery for Neurodegenerative Disease -... - October 4th, 2022
- Laser Focus World highlights UC research that uses light to restore cell function - University of Cincinnati - October 4th, 2022
- CAR T-Cell Therapy Shows Promise in Treating Lupus - Healthline - September 25th, 2022
- ProKidney to Present at the Jefferies Cell and Genetic Medicine Summit - El Paso Inc. - September 25th, 2022
- Allogene Therapeutics Announces Participation in the Jefferies Cell and Genetic Medicine Summit - GlobeNewswire - September 25th, 2022
- Alzheimer's disease risk linked to newly discovered protein mutation - Medical News Today - September 25th, 2022
- Biological Links Identified Between an Aggressive Breast Cancer Type and African Ancestry - Weill Cornell Medicine Newsroom - September 25th, 2022
- The Use of Nanorobotics in the Treatment Therapy of Cancer and Its Future Aspects: A Review - Cureus - September 25th, 2022
- UW Health, UW-Madison School of Medicine and Public Health: Innovative clinical trial targets recurrent BK infection in kidney transplant recipients -... - September 25th, 2022
- Shutting down backup genes leads to cancer remission in mice - University of Michigan News - September 25th, 2022
- Pembrolizumab in Combination with Lenvatinib as First-Line Treatment for Non Clear Cell Renal Cell Carcinoma (nccRCC), KEYNOTE-B61 - Laurence Albiges... - September 25th, 2022
- FDA's ODAC Votes That Benefits Do Not Outweigh Risks for Poziotinib in HER Exon 20 Ins+ NSCLC - Targeted Oncology - September 25th, 2022
- Courageous Lanarkshire teen who survived leukaemia thanks to a clinical trial pursues nursing dream - Daily Record - September 25th, 2022
- Discovery Reveals How the Immune System Tolerates Friendly Gut Bacteria - Weill Cornell Medicine Newsroom - September 8th, 2022
- Study: New Factors Are Associated With Increased PFS from BCMA-Targeted T-Cell Therapy - Pharmacy Times - September 8th, 2022
- Study Uncovers Possible Path for Improving T Cell Therapies - University of Arizona - September 8th, 2022
- Trodelvy Significantly Improved Overall Survival in Pre-Treated HR+/HER2- Metastatic Breast Cancer Patients in TROPiCS-02 Study - Gilead Sciences - September 8th, 2022
- Manipulating Astrocytes in Tumor Environment Effective Against Glioblastoma - Inside Precision Medicine - September 8th, 2022
- Jane Fonda Diagnosed with Non-Hodgkin's Lymphoma: What to Know - Healthline - September 8th, 2022
- Dr Hatim Husain: Biomarker Testing Is a Treatment Cornerstone in NSCLC - AJMC.com Managed Markets Network - August 30th, 2022
- Porton Advanced and Kun Tuo Announce Strategic Partnership to Deepen Gene and Cell Therapy CDMO and Clinical Research Services - PR Newswire - August 30th, 2022
- The Role of Eosinophils as a Biomarker to Inform Treatment Decisions for Patients With COPD - Consultant360 - August 30th, 2022
- Scientists Discover Surprise Anticancer Properties of Common Lab Molecule | Newsroom - UNC Health and UNC School of Medicine - August 30th, 2022
- Overall survival is similar for patients receiving CT-based or minimal follow-up after surgical resection of non-small-cell lung cancer - 2 Minute... - August 30th, 2022
- NSF Grant to Aid OSU Researchers Developing Treatment for Canine Cancer - The Corvallis Advocate - August 30th, 2022
- Researchers Identify the Target of Immune Attacks on Liver Cells in Metabolic Disorders - Weill Cornell Medicine Newsroom - August 22nd, 2022
- Why Is CAR T-Cell Therapy One of the Most Phenomenal Advances in Science? - University of Colorado Anschutz Medical Campus - August 22nd, 2022
- Porton Advanced Solutions completes a Series B financing round to expand its end-to-end Gene and Cell Therapy CDMO Platforms - PR Newswire - August 22nd, 2022
- Cell Analysis Global Market Report 2022: Growing Focus on Personalized Medicine & Introduction of Advanced Technologies in Cell Analysis Presents... - August 22nd, 2022
- Stress can throw off circadian rhythms and lead to weight gain - Medical News Today - August 22nd, 2022
- Cell Stress and Mitochondrial Dysfunction Found in Early Alzheimers Disease Patients, Findings Published in Science Translational Medicine - BioSpace - August 22nd, 2022
- Restoring cell and organ function after the heart stops - National Institutes of Health (.gov) - August 22nd, 2022
- Rolling the Dice: Gamble Pays Off For Cancer Patient in CAR T-Cell Clinical Trial - University of Colorado Anschutz Medical Campus - August 22nd, 2022
- Boosting neuron formation restores memory in mice with Alzheimer's disease - EurekAlert - August 22nd, 2022
- UTSW study finds p53 gene plays second role in suppressing genes tied to cancer - UT Southwestern - August 22nd, 2022
- GlyNAC supplementation reverses mitochondrial dysfunction, oxidative stress and aging hallmarks to boost strength and promote health in aging humans -... - August 22nd, 2022
- Multiple shots of the BCG vaccine protect type 1 diabetics from COVID-19 - EurekAlert - August 22nd, 2022
- Cell Regeneration Medicine Market Analysis by Type, Application, Growth, Demand, Status, and Forecast from 2022 to 2032 - Digital Journal - August 5th, 2022
- Higher Hydroxyurea Exposure Tied to Better Blood Parameters in US... - Sickle Cell Anemia News - August 5th, 2022
- Kiwis with multiple sclerosis patients thriving from overseas stem-cell treatment urge Government to approve it here - Newshub - July 27th, 2022
- MHRA grants marketing authorisation to Global Blood Therapeutics for sickle cell disease drug - PMLiVE - July 27th, 2022
- CAR T-Cell Therapy Turns 10 and Finally Earns the Word 'Cure' - Medscape - July 27th, 2022
- Oncology Peer Review On-The-Go: The Prognostic Significance of Peripheral Blood Biomarkers in Patients With Advanced NonSmall Cell Lung Cancer Treated... - July 27th, 2022
- CRISPR therapeutics can damage the genome - EurekAlert - July 27th, 2022
- To cell surface and beyond: Tracing subcellular glycoprotein transport using modified cholera toxin - EurekAlert - July 27th, 2022
- From Donor to Patient: Advancing the Future of Cell Therapies - Genetic Engineering & Biotechnology News - July 27th, 2022
- Five-Year Review of Biomedical Research Imaging Center, Center Director | Newsroom - UNC Health and UNC School of Medicine - July 27th, 2022
- Using Particles That Are Smaller Than the Head of a Pin to Treat Cancer - Yale School of Medicine - July 11th, 2022
- Stem Cell Assays Market Report 2022-2027: Increasing Awareness About Therapeutic Potency of Stem Cells Driving Growth - ResearchAndMarkets.com -... - July 11th, 2022
- Sickle cell disease could be treated with common plant, study finds - The Telegraph - July 11th, 2022
- Unexpected link between most common cancer drivers may yield more effective drugs - University of Wisconsin-Madison - July 11th, 2022
- Scientists Discover Key to Hepatitis A Virus Replication, Show Drug Effectiveness | Newsroom - UNC Health and UNC School of Medicine - July 11th, 2022
- How Erectile Dysfunction Drugs Can Help Treat Cancer and Save Thousands of Lives - SciTechDaily - July 11th, 2022
- Pune: Dr Mohan Wani appointed as director of National Centre for Cell Science - The Indian Express - July 11th, 2022
- Kite's CAR T-cell Therapy Yescarta Granted European Marketing Authorization for the Treatment of Relapsed or Refractory Follicular Lymphoma - Gilead... - July 3rd, 2022
- Important Factors for Regulating the Body's Immune Response - Neuroscience News - July 3rd, 2022
- Stem Cell Therapy Market Is Expected To Reach USD 455.61 Billion By 2027 At A CAGR Of 16 percent By Forecast 2027 Says Maximize Market Research (MMR)... - July 3rd, 2022
- Neurona Therapeutics Announces Initial Subject Dosed in First Clinical Trial of Regenerative Human Cell Therapy, NRTX-1001, in Adults with... - July 3rd, 2022
- Growing scope of Genetic Medicine and Stem Cell Research - The Hindu - June 22nd, 2022
- When children with sickle cell grow up, they face a system not designed for them - 89.3 WFPL News Louisville - June 22nd, 2022
- Precision BioSciences Announces In Vivo Gene Editing Collaboration with Novartis to Develop Potentially Curative Treatment for Disorders Including... - June 22nd, 2022
- Stem Cell Assays Market worth $4.5 billion by 2027 - Exclusive Report by MarketsandMarkets - PR Newswire - June 22nd, 2022
- Bringing heart and humanity to hematology | News | Harvard TH Chan School of Public Health - HSPH News - June 22nd, 2022
- Belzutifan Improves Survival in Patients With RCC and VHL - Targeted Oncology - June 22nd, 2022
- Immatics and Editas Medicine Enter Strategic Research Collaboration and Licensing Agreement to Combine Gamma-Delta T Cell Adoptive Cell Therapies and... - June 13th, 2022
- ASCO 2022: Gilead's tough weekend, bispecific progress and 'gamma delta' cell therapy - BioPharma Dive - June 13th, 2022